Novel Triazolopyridine Derivatives as DGAT2 Inhibitors for Treating Multiple Diseases.
Rachel MataPublished in: ACS medicinal chemistry letters (2024)
Provided herein are novel triazolopyridine derivatives as DGAT2 inhibitors, pharmaceutical compositions, use of such compounds in treating multiple diseases, and processes for preparing such compounds.
Keyphrases